The past decade has seen “far too few devices” on the US market designed specifically for diagnosing and treating pediatric populations despite recent legislative actions, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb said during a public workshop Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,